Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.

Harry D BearWen WanAndré RobidouxPeter RubinSteven LimentaniRichard L WhiteJames GranfortunaJudith O HopkinsDwight OldhamAngel RodriguezAmy P Sing

Published in: Journal of surgical oncology (2017)

Using the RS to guide NST is feasible. These results suggest that for patients with RS < 25 NHT is a potentially effective strategy.

Keyphrases